Shafferman; Avigdor

Patent Applications and Registrations

Patent applications and USPTO patent grants for Shafferman; Avigdor.The latest application filed is for "bacillus anthracis htra-defective-derived vaccines".

Company Profile

0.12.8

Shafferman; Avigdor - Nes Ziona N/A IL
Shafferman; Avigdor - Nexx Ziona IL
Shafferman; Avigdor - Ness Ziona N/A IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Bacillus anthracis HtrA-defective-derived vaccines Grant 9,713,637 - Cohen , et al. July 25, 2	2017-07-25
Uniformly conjugated serine hydrolases Grant 8,980,609 - Cohen , et al. March 17, 2	2015-03-17
BACILLUS ANTHRACIS HtrA-DEFECTIVE-DERIVED VACCINES App 20140170188 - Cohen; Ofer ; et al.	2014-06-19
Malaria vaccine compositions and constituents which elicit cell mediated immunity Grant 8,728,492 - Shafferman , et al. May 20, 2	2014-05-20
Diagnosis of Bacillus anthracis infection based on detection of bacterial secreted biomarkers Grant 8,591,899 - Shafferman , et al. November 26, 2	2013-11-26
Recombinant BCG tuberculosis vaccine designed to elicit immune responses to mycobacterium tuberculosis in all physiological stages of infection and disease Grant 8,361,482 - Shafferman , et al. January 29, 2	2013-01-29
Diagnosis Of Bacillus Anthracis Infection Based On Detection Of Bacterial Secreted Biomarkers App 20120015379 - Shafferman; Avigdor ; et al.	2012-01-19
Malaria Vaccine Compositions And Constituents Which Elicit Cell Mediated Immunity App 20110206714 - Shafferman; Avigdor ; et al.	2011-08-25
Novel Recombinant BCG Tuberculosis Vaccine Designed to Elicit Immune Responses to Mycobacterium Tuberculosis in all Physiological Stages of Infection and Disease App 20110117133 - Shafferman; Avigdor ; et al.	2011-05-19
Recombinant BCG tuberculosis vaccine designed to elicit immune responses to Mycobacterium tuberculosis in all physiological stages of infection and disease Grant 7,670,609 - Shafferman , et al. March 2, 2	2010-03-02
Uses of chemically-modified cholinesterases for detoxification of organophosporus compounds Grant 7,572,764 - Cohen , et al. August 11, 2	2009-08-11
Novel Recombinant Bcg Tuberculosis Vaccine Designed To Elicit Immune Responses To Mycobacterium Tuberculosis In All Physiological Stages Of Infection And Disease App 20090136534 - Shafferman; Avigdor ; et al.	2009-05-28
Uniformly Conjugated Serine Hydrolases App 20090068165 - Cohen; Ofer ; et al.	2009-03-12
Uses of chemically-modified cholinesterases for detoxification of organophosporus compounds App 20040147002 - Cohen, Ofer ; et al.	2004-07-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.